Zhibaidihuang Decoction Ameliorates Cell Oxidative Stress by Regulating the Keap1-Nrf2-ARE Signalling Pathway

Abstract EN

Zhibaidihuang decoction (ZBDHD) is a Chinese herbal formula, which is used in Chinese traditional medicine to treat symptoms of Yinxuhuowang (Yin deficiency and high fire) syndrome.

This study elucidates the mechanism of ZBDHD on oral ulcers, one Yinxuhuowang syndrome.

Simultaneously, some ingredients in ZBDHD were found and identified by ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).

A Ganjiangfuzirougui decoction- (GJD-) induced Yinxuhuowang syndrome SD rat model was used to demonstrate the efficiency of ZBDHD treatment.

The oral mucosa of rat in the GJD group, stained with hematoxylin and eosin (H&E), showed epidermal shedding and inflammatory cell infiltration.

And an alleviation efficiency of ZBDHD in GJD-induced pathological changes in the oral mucosa could be obtained.

ZBDHD treatment restored the GJD-induced imbalance of metabolites, which were choline, glycocholic acid, and palmitoyl-L-carnitine (PALC).

GJD stimulated the expression of NF-κB.

And the overexpressed of NF-κB in mucosa of rat in the GJD group could be inhibited by ZBDHD treatment.

Simultaneously, the optimal efficiency of ZBDHD treatment on the cellular ATP content, oxygen consumption rate (OCR), and superoxide dismutase (SOD) concentration was evaluated, in vitro assay.

Compared to the control cells, the ATP content, OCR, and SOD activity in the ZBDHD-treated cells were significantly higher.

For the mechanisms study, seven cytokines were screened with a Dual-Luciferase Reporter gene assay.

In the ARE assay, the luciferase signal was stimulated significantly by ZBDHD.

In cells, the transcription of nrf2, maf, and keap1, which were related to the ARE pathway, was elevated by ZBDHD treatment.

Our study demonstrated that high-dose GJD could lead to Yinxuhuowang syndrome, such as oral ulcers, and the imbalance in serum metabolites.

And ZBDHD can improve oral cell inflammation and the imbalance of metabolism by inhibiting NF-κB and enhancing the activity of the ARE signalling pathway to ameliorate oxidative stress in the cell.

This study provides a theoretical basis for the clinical application of ZBDHD.